[video=youtube_share;0QqAzs0TF6A]http://youtu.be/0QqAzs0TF6A[/video]
Police sergeant gives Congressional testimony of how Dr. Burzynski’s treatment cured his daughter of cancer, but she died from chemotherapy.
http://healthimpactnews.com/2014/cancer-patients-die-as-fda-restricts-dr-burzynskis-treatment/
Although his clinic utilizes a broad spectrum of cancer treatments, Dr. Burzynski is perhaps best-known for his discovery and development of antineoplastons, which are peptides and amino acid derivatives that activate tumor suppressing-genes. Antineoplastons have also been proven to be an effective cancer treatment via independent research by Japan’s Dr. Hidaeki Tsuda of the Kurume University Hospital. Until the 1990s, Dr. Burzynski used antineoplastons, sometimes in conjunction with traditional oncology agents, to treat and cure cancer patients.
Over the past several decades, the conventional medical establishment, via a succession of relentless attacks, has slowly choked off patient access to antineoplastons. After 1998, and at the insistence of the FDA, treatment with antineoplastons was limited to patients in registered FDA trials. Despite the incredible expense of FDA-registered clinical trials and the small likelihood that—given the FDA’s clear bias towards Big Pharma “cures” and their continued persecution of Dr. Burzynski—antineoplastons would ever win FDA approval, Dr. Burzynski has been able to treat patients with antineoplastons only via FDA clinical trials. This is yet another FDA “Catch-22”: they’ve forced Dr. Burzynski to conduct expensive clinical trials, with the full knowledge and likelihood that even after trials, antineoplastons would not be approved!
Police sergeant gives Congressional testimony of how Dr. Burzynski’s treatment cured his daughter of cancer, but she died from chemotherapy.
http://healthimpactnews.com/2014/cancer-patients-die-as-fda-restricts-dr-burzynskis-treatment/
Although his clinic utilizes a broad spectrum of cancer treatments, Dr. Burzynski is perhaps best-known for his discovery and development of antineoplastons, which are peptides and amino acid derivatives that activate tumor suppressing-genes. Antineoplastons have also been proven to be an effective cancer treatment via independent research by Japan’s Dr. Hidaeki Tsuda of the Kurume University Hospital. Until the 1990s, Dr. Burzynski used antineoplastons, sometimes in conjunction with traditional oncology agents, to treat and cure cancer patients.
Over the past several decades, the conventional medical establishment, via a succession of relentless attacks, has slowly choked off patient access to antineoplastons. After 1998, and at the insistence of the FDA, treatment with antineoplastons was limited to patients in registered FDA trials. Despite the incredible expense of FDA-registered clinical trials and the small likelihood that—given the FDA’s clear bias towards Big Pharma “cures” and their continued persecution of Dr. Burzynski—antineoplastons would ever win FDA approval, Dr. Burzynski has been able to treat patients with antineoplastons only via FDA clinical trials. This is yet another FDA “Catch-22”: they’ve forced Dr. Burzynski to conduct expensive clinical trials, with the full knowledge and likelihood that even after trials, antineoplastons would not be approved!
